M.D. Anderson Cancer Center: all 3,044 studies

Page 22 of 31. Open to participants first (578), then studies with results posted, then the rest; newest registration first within each.

• Behavioral Activation Therapy and Nicotine Replacement Therapy in Increasing Smoking CessationActive, not recruitingNCT02697227Not applicable
• Nivolumab and Radiation Therapy With or Without Ipilimumab in Treating Patients With Brain Metastases From Non-small Cell Lung CancerActive, not recruitingNCT02696993Phase 1/2
• Dasatinib and Venetoclax in Treating Patients With Philadelphia Chromosome Positive or BCR-ABL1 Positive Early Chronic Phase Chronic Myelogenous LeukemiaActive, not recruitingNCT02689440Phase 2
• Evaluation of Satisfaction With Quality of Care on the Palliative Care UnitCompletedNCT02686411
• Autologous Fat Grafting Techniques in Patients Undergoing Reconstructive SurgeryCompletedNCT02677012
• Ipilimumab (Immunotherapy) and MGN1703 (TLR Agonist) in Patients With Advanced Solid MalignanciesTerminatedNCT02668770Phase 1
• Intensity-Modulated Proton Therapy (IMPT) or TransOral Robotic Surgery (TORS) for the Treatment of Low-Risk Oropharynx Squamous CellStatus unknownNCT02663583
• Cough, Expiratory Training, and Chronic Aspiration After Head and Neck RadiotherapyActive, not recruitingNCT02662907Not applicable
• Adavosertib Before Surgery in Treating Patients With Advanced High Grade Ovarian, Fallopian Tube, or Primary Peritoneal CancerActive, not recruitingNCT02659241Early Phase 1
• LY2510924, Idarubicin and Cytarabine in Patients With Relapsed or Refractory Acute Myeloid LeukemiaCompletedNCT02652871Phase 1
• Prexasertib (LY2606368), Cytarabine, and Fludarabine in Patients With Relapsed or Refractory Acute Myeloid Leukemia or High-Risk Myelodysplastic SyndromeCompletedNCT02649764Phase 1
• Randomized AmnioFix Study During Radical ProstatectomyWithdrawnNCT02645591Phase 2
• Ibrutinib, Fludarabine Phosphate, Cyclophosphamide, and Obinutuzumab in Treating Patients With Chronic Lymphocytic LeukemiaActive, not recruitingNCT02629809Phase 2
• Radiation Therapy in Treating Patients With Hepatocellular Carcinoma, Cholangiocarcinoma, or Liver Metastasis Who Have Impaired Liver FunctionTerminatedNCT02626312Phase 1
• Tremelimumab With or Without Cryoablation in Treating Patients With Metastatic Kidney CancerCompletedNCT02626130Early Phase 1
• Bioelectrical Impedance Analysis in Estimating Body Composition in Patients With Stage I-IV Head and Neck Cancer Undergoing Radiation TherapyActive, not recruitingNCT02615275Not applicable
• Accelerated Enhanced RECOVERy Following Minimally Invasive Colorectal Cancer Surgery (RecoverMI)CompletedNCT02613728Not applicable
• Safety Evaluation of Intra-Operative MRI-Based Guidance for Laser Ablation of Epidural MetastasisCompletedNCT02613390Not applicable
• Houston Independent School District (HISD) Yoga EvaluationTerminatedNCT02606591Not applicable
• Personalized Peptide Vaccine in Treating Patients With Advanced Pancreatic Cancer or Colorectal CancerActive, not recruitingNCT02600949Phase 1
• Phase II Sorafenib With Radiation and Temozolomide in Newly Diagnosed Glioblastoma or GliosarcomaWithdrawnNCT02599090Phase 2
• Effect of Cabozantinib S-Malate or Lenvatinib Mesylate on Weight and Body Composition in Patients With Metastatic Endocrine CancerCompletedNCT02592356Not applicable
• Feasibility of Short Breast MRI (SBMRI) for Screening Patients at High Risk for Breast CancerCompletedNCT02590458Early Phase 1
• Ascending Dose and Exploratory Expansion Study of DS-3032b, an Oral MDM2 Inhibitor, in Subjects With Relapsed and/or Refractory Multiple MyelomaTerminatedNCT02579824Phase 1
• Neuromodulation as a Treatment for Chemotherapy-Induced Peripheral NeuropathyActive, not recruitingNCT02573766Not applicable
• Perception of Palliative Care EncounterCompletedNCT02558257
• Neurofeedback in Decreasing Acute Radiotherapy-Induced Pain in Patients With Head and Neck CancerActive, not recruitingNCT02543320Not applicable
• A Phase Ib Study of Belinostat With RDHAP Chemotherapy (Dexamethasone, Cytarabine, Cisplatinum) in Adults With Relapsed or Refractory Diffuse Large B-cell LymphomaWithdrawnNCT02532192Phase 1
• Nivolumab and/or Ipilimumab With or Without Azacitidine in Treating Patients With Myelodysplastic SyndromeActive, not recruitingNCT02530463Phase 2
• Mesenchymal Stem Cells (MSC) for Ovarian CancerCompletedNCT02530047Phase 1
• Hu8F4 in Treating Patients With Advanced Hematologic MalignanciesActive, not recruitingNCT02530034Phase 1
• CD19-Specific T-cells in Treating Patients With Advanced Lymphoid MalignanciesCompletedNCT02529813Phase 1
• MPDL3280A With Chemoradiation for Lung CancerActive, not recruitingNCT02525757Phase 2
• Edmonton Symptom Assessment Scale: Self-Completion vs. Assisted-CompletionCompletedNCT02523378Not applicable
• Occupational Therapy in Palliative CareTerminatedNCT02521194Not applicable
• Preliminary Testing of the MD Anderson Symptom Inventory (Adolescent Version)Active, not recruitingNCT02515383
• Comparison of Progel Sealant to Standard of Care (SOC) for Patients Undergoing DecorticationWithdrawnNCT02511600Phase 3
• Registry Study for Personalized Cancer TherapyCompletedNCT02508662
• Rivaroxaban Utilization for Treatment and Prevention of Thromboembolism in Cancer Patients: Experience at a Comprehensive Cancer CenterCompletedNCT02502396
• Message 2: The Effect of Message Content and Clinical Outcome on Patient's Perception of Physician CompassionCompletedNCT02498899Not applicable
• Ultra Low Dose Orbital Radiation Therapy in Treating Patients With Stage I-IV Indolent B-cell Lymphoma or Mantle Cell LymphomaActive, not recruitingNCT02494700Phase 2
• Couples-Based Yoga Program in Improving Quality of Life in Patients With High-Grade Glioma Undergoing Radiation Therapy and Their PartnersActive, not recruitingNCT02481349Not applicable
• Middle and High School Students' Reactions to a Health Interactive Website: ASPIRE ReactionsCompletedNCT02469779Not applicable
• Prospective Study to Determine Impact of Early Palliative Care Consult on Quality of Life (QOL), Cancer Related Symptoms In Advanced Lung Cancer Patients: Thoracic Pilot ProjectCompletedNCT02459002
• Feasibility and Identification of Breast Cancer Patients for Potential Avoidance of SurgeryActive, not recruitingNCT02455791Not applicable
• Genomic Profiling Assay in Phase ICompletedNCT02437617
• Effects of a Group Residential Retreat on Cancer OutcomesWithdrawnNCT02429544Not applicable
• Ibrutinib, Rituximab, and Consolidation Chemotherapy in Treating Young Patients With Newly Diagnosed Mantle Cell LymphomaActive, not recruitingNCT02427620Phase 2
• Ultraviolet (UV) Photography in AdolescentsCompletedNCT02426853Early Phase 1
• Fucosylated T Cells for Graft Versus Host Disease (GVHD) PreventionCompletedNCT02423915Phase 1
• Changes in Patient Reported Constipation Among Advanced Cancer Patients After Receiving an Educational InterventionCompletedNCT02422329Not applicable
• Urelumab (CD137 mAb) With Rituximab for Relapsed, Refractory or High-risk Untreated Chronic Lymphocytic Leukemia (CLL) PatientsWithdrawnNCT02420938Phase 2
• Elotuzumab and Lenalidomide After Stem Cell Transplant in Treating Patients With Newly Diagnosed Multiple MyelomaActive, not recruitingNCT02420860Phase 2
• Ixazomib Citrate With Gemcitabine Hydrochloride and Doxorubicin Hydrochloride in Treating Patients With Urothelial Cancer That is Metastatic or Cannot Be Removed by SurgeryActive, not recruitingNCT02420847Phase 1/2
• Use of High-Resolution Microendoscopy (HRME) in Patients With Cervical DysplasiaCompletedNCT02420665Early Phase 1
• Vorinostat and Temsirolimus With or Without Radiation Therapy in Treating Younger Patients With Newly Diagnosed or Progressive Diffuse Intrinsic Pontine GliomaCompletedNCT02420613Phase 1
• AMG 208 Tumor Microenvironment in Metastatic Castration Resistant Prostate Cancer (mCRPC)WithdrawnNCT02420587Phase 2
• Phase IB Study to Evaluate the Safety of Selinexor (KPT-330) in Combination With Multiple Standard Chemotherapy or Immunotherapy Agents in Patients With Advanced MalignanciesTerminatedNCT02419495Phase 1
• Bone Marrow Derived Mesenchymal Stem Cells in Improving Heart Function in Patients With Heart Failure Caused by AnthracyclinesCompletedNCT02408432Phase 1
• Tumor-Specific Clonotype, Metabolic Profile, and PET/CT in Predicting Chemotherapy Response in Patients With Relapsed or Refractory Diffuse Large B-cell LymphomaCompletedNCT02405078Early Phase 1
• Levonorgestrel-Releasing Intrauterine System With or Without Everolimus in Treating Patients With Atypical Hyperplasia or Stage IA Grade 1 Endometrial CancerActive, not recruitingNCT02397083Phase 2
• Nab-Paclitaxel, Capecitabine, and Radiation Therapy Following Induction Chemotherapy in Treating Patients With Locally Advanced Pancreatic CancerCompletedNCT02394535Phase 1
• ONC201 in Treating Patients With Relapsed or Refractory Acute Leukemia or High-Risk Myelodysplastic SyndromeTerminatedNCT02392572Phase 1/2
• Study of Loratadine for Pegfilgrastim Induced Bone Pain in Patients With Aggressive LymphomaTerminatedNCT02392039Early Phase 1
• Ganetespib in Combination With Paclitaxel, Carboplatin, and Radiation Therapy in Treating Patients With Stage II-III Esophageal CancerCompletedNCT02389751Phase 1
• Dasatinib, Temsirolimus, and Cyclophosphamide in Treating Patients With Advanced, Recurrent, or Refractory Solid TumorsActive, not recruitingNCT02389309Phase 1
• Cement Augmentation in Preventing Vertebral Body Compression Fracture Following Spine Stereotactic Radiosurgery in Patients With Solid Tumors and Spinal MetastasesActive, not recruitingNCT02387905Phase 2
• 18F-FSPG PET in Imaging Patients With Liver Cancer Before Undergoing Surgery or TransplantActive, not recruitingNCT02379377Phase 1
• Interventional Validation of an MDS-Specific Measure of Quality of Life: Assessing the Responsiveness of the Quality of Life in Myelodysplasia Scale (QUALMS-1) to Different Hypomethylating Agent Regimens for Low and Intermediate Risk DiseaseCompletedNCT02378701
• Patient Controlled Administration of Methylphenidate for Cancer Related Fatigue - PRN MethylphenidateCompletedNCT02361125Phase 1
• Message: Study of Patients' Perception of Physician's CompassionCompletedNCT02357108Not applicable
• Mindfulness Based Couples TherapyCompletedNCT02349217Not applicable
• Phase II Study of Pazopanib and Topotecan in Cervical CancerWithdrawnNCT02348398Phase 2
• Cordotomy for Refractory Cancer PainCompletedNCT02345629Not applicable
• Web-Based Family Outreach Program for Cancer Prevention in High-Risk FamiliesActive, not recruitingNCT02337452
• Cervical Cancer Screening Study in BrazilCompletedNCT02335372Not applicable
• Tc99m Sestamibi Molecular Breast ImagingActive, not recruitingNCT02324387Not applicable
• Ceritinib and Everolimus in Treating Patients With Locally Advanced or Metastatic Solid Tumors or Stage IIIB-IV Non-small Cell Lung CancerActive, not recruitingNCT02321501Phase 1
• Talazoparib in Determining Genetic Effects on Disease Response in Patients With Advanced Ovarian, Fallopian Tube, or Primary Peritoneal CancerCompletedNCT02316834Early Phase 1
• Preoperative Rehabilitation During Neoadjuvant Therapy for Pancreatic CancerCompletedNCT02295956Early Phase 1
• PCORI-CER-1306-03385 Lung Cancer Screening Readiness StudyStatus unknownNCT02292485
• Neurological Effects of Acupuncture to Prevent Radiation-induced XerostomiaCompletedNCT02292368Not applicable
• Talazoparib in Treating Patients With Recurrent, Refractory, Advanced, or Metastatic Cancers and Alterations in the BRCA GenesActive, not recruitingNCT02286687Phase 2
• Cord Blood Natural Killer (NK) Cells in Leukemia/LymphomaCompletedNCT02280525Phase 1
• Molecular Testing and Imaging in Improving Response in Patients With Stage I-III Triple-Negative Breast Cancer Receiving Chemotherapy MDACC Breast Moonshot InitiativeActive, not recruitingNCT02276443Not applicable
• Infusion of Allogeneic, 3rd Party CD19-specific T CellsWithdrawnNCT02274506Phase 1
• Rational Therapeutics Based on Matched Tumor and Normal TissueCompletedNCT02272595
• Expanded Natural Killer Cell Infusion in Treating Younger Patients With Recurrent/Refractory Brain TumorsCompletedNCT02271711Phase 1
• Trial of PCI-32765 (BTK Inhibitor) in Combination With Carfilzomib in Relapse/Refractory Mantle Cell LymphomaTerminatedNCT02269085Phase 1
• Exploring the Neuro-Immune Basis of Cancer-Related Fatigue Using Behavioral MeasuresCompletedNCT02255773Not applicable
• Sensor-Assisted Prevention of Dehydration in Head and Neck Cancer PatientsActive, not recruitingNCT02253238Not applicable
• Diagnostic Aids for Detection and Diagnosis of Oral CancerWithdrawnNCT02251639Phase 1
• Venetoclax and Sequential Busulfan, Cladribine, and Fludarabine Phosphate Before Donor Stem Cell Transplant in Treating Patients With Acute Myelogenous Leukemia or Myelodysplastic SyndromeActive, not recruitingNCT02250937Phase 2
• Fluoro-L-Thymidine Positron Emission Tomography (FLT PET) vs. Adv. Magnetic Resonance (MR) Techniques in Recurrent GliomaWithdrawnNCT02241668Not applicable
• Ipilimumab and Stereotactic Body Radiation Therapy (SBRT) in Advanced Solid TumorsCompletedNCT02239900Phase 1
• Dabrafenib and Trametinib Before and After Surgery in Treating Patients With Stage IIIB-C Melanoma With BRAF V600 MutationActive, not recruitingNCT02231775Phase 2
• An Open-Label, Phase I/II Study of Nilotinib (Tasigna) and MEK-162 (ARRY-162) Used in Combination for Patients With Refractory or Advanced Chronic Myeloid Leukemia and Philadelphia Positive Acute Leukemia (Protocol CAMN107AUS41T)TerminatedNCT02225574Phase 1
• Robotic Surgery for Oropharyngeal Squamous Cell CarcinomaTerminatedNCT02225496Phase 2
• Cisplatin, Docetaxel, and Nintedanib Before Surgery in Treating Patients With Previously Untreated Stage IB-IIIA Non-small Cell Lung CancerCompletedNCT02225405Phase 1
• Massage Therapy in Reducing Chemotherapy-Induced Peripheral Neuropathy in Patients With Gastrointestinal or Breast MalignanciesActive, not recruitingNCT02221700Not applicable

← M.D. Anderson Cancer Center overview and focus areas